SciSight Ecosystem
WoS SCIE Q4Scopus Q2SCImago #8,529CAS 4区Hybrid

Journal of Biopharmaceutical Statistics

Abbreviation (ISO):J. Biopharm. Stat
Country: United States•WoS SCIE Quartile: Q4•Scopus SJR: 0.68•SCImago Rank: #8,529•Identifier (ISSN):1054-3406(Print)/1520-5711(Online)•Articles / Year: 48•Estimated Publication Fee (APC): $3,110 USD
Clarivate IF (2026)Q4
1.3
↑ +0.1

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
43

43 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate16.7%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
48articles/year
4.09% Gold OA•98.7% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.50pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q2(IF: 1.3)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.50đ
WoS Q2(IF: 1.3)
🔵 Computed
20251.50đ
WoS Q2(IF: 1.2)
🔵 Computed
20241.50đ
WoS Q2(IF: 1.2)
🔵 Computed
20231.50đ
WoS Q2(IF: 1.1)
🔵 Computed
20221.50đ
WoS Q2(IF: 1.503)
🔵 Computed
20211.50đ
WoS Q2(IF: 1.051)
🔵 Computed
20201.50đ
WoS Q2(IF: 0.601)
🔵 Computed
20191.50đ
WoS Q2(IF: 0.756)
🔵 Computed
20181.50đ
WoS Q2(IF: 0.638)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

The Journal of Biopharmaceutical Statistics, a rapid publication journal, discusses quality applications of statistics in biopharmaceutical research and development. Now publishing six times per year, it includes expositions of statistical methodology with immediate applicability to biopharmaceutical research in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers: Drug, device, and biological research and development; Drug screening and drug design; Assessment of pharmacological activity; Pharmaceutical formulation and scale-up; Preclinical safety assessment; Bioavailability, bioequivalence, and pharmacokinetics; Phase, I, II, and III clinical development including complex innovative designs; Premarket approval assessment of clinical safety; Postmarketing surveillance; Big data and artificial intelligence and applications.

Topics Covered (Recognized by AI)
Mathematics91.7%Computer science84%Statistics83.2%Medicine76%Internal medicine62.4%Economics59.2%Biology57.6%Econometrics48.4%Pathology45.2%Machine learning42.1%Bioinformatics36.2%Artificial intelligence35.7%Physics35.1%Clinical trial28.4%Chemistry24.2%Philosophy20.7%Surgery20.6%Sample size determination20.4%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #8,529Scopus Q2SCImago Profile
Scopus Coverage:1991-2026
Scopus Broad Areas:MathematicsMedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q2
0.68

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q2
Scopus H-Index (2025)
60

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
1.26

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,110 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations313
3-Year Documents216
Citable Documents200

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate42.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

PharmacologyQ2
Pharmacology (medical)Q2
Statistics and ProbabilityQ2

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Taylor and Francis Ltd.
Publication Language
English
Frequency
Bimonthly
Founding Year
1991
Editorial Address
TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
PHARMACOLOGY & PHARMACY
JCRSCIE
299/356Q4
STATISTICS & PROBABILITY
JCRSCIE
84/170Q2
PHARMACOLOGY & PHARMACY
JCISCIE
197/356Q3
STATISTICS & PROBABILITY
JCISCIE
76/170Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—550
20251.29351
20241.2102150
20231.198352
20221.50384422
20211.05157418
20200.60171726
20190.75694803
20180.63854419
2017—1051,015
2016—79539
2015—78782
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Journal of Biopharmaceutical Statistics

WoS Q4
0112201820192020202120222023202420251.20
Annual Impact Factor Metric
2025:1.2

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 16.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 2d8df94b-425e-44ab-8691-b6b19b1aef6f
Database Updated: 2026-09-29